SCHEMBL30055906

SCHEMBL30055906

Cc1sccc1-c1cc(=O)oc2cc(OC(C)C(=O)N3CCC[C@H](C(=O)O)C3)ccc12

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.54
▸ CYP2C9 P11712 1/20 0.54
▸ CYP2C19 P33261 1/20 0.54
▸ RAB9A P51151 1/20 0.51
▸ ALDH1A1 P00352 8/20 0.49
▸ KDM4E B2RXH2 8/20 0.49
▸ HPGD P15428 6/20 0.49
▸ KMT2A Q03164 3/20 0.43
▸ HTT P42858 2/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ MAPT P10636 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ HSD17B10 Q99714 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ USP2 O75604 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ RCE1 Q9Y256 1/20 0.41
▸ MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20839159 1.00 CYP3A4 (0.54) CYP3A4CYP2C9CYP2C19RAB9AALDH1A1
SCHEMBL20839161 1.00 CYP3A4 (0.54) CYP3A4CYP2C9CYP2C19RAB9AALDH1A1
SCHEMBL22431759 1.00 CYP3A4 (0.54) CYP3A4CYP2C9CYP2C19RAB9AALDH1A1
SCHEMBL20839380 0.89 CYP3A4 (0.53) CYP3A4CYP2C9CYP2C19RAB9AALDH1A1
SCHEMBL30762847 0.89 CYP3A4 (0.53) CYP3A4CYP2C9CYP2C19RAB9AALDH1A1
SCHEMBL20839381 0.89 CYP3A4 (0.53) CYP3A4CYP2C9CYP2C19RAB9AALDH1A1
SCHEMBL20839165 0.89 ALDH1A1 (0.59) CYP3A4CYP2C9CYP2C19RAB9AALDH1A1
SCHEMBL30763100 0.89 ALDH1A1 (0.59) CYP3A4CYP2C9CYP2C19RAB9AALDH1A1
SCHEMBL20848072 0.89 ALDH1A1 (0.59) CYP3A4CYP2C9CYP2C19RAB9AALDH1A1
SCHEMBL20839151 0.89 CYP3A4 (0.56) CYP3A4CYP2C9CYP2C19RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4333822-A1 COMPOSITION COMPRISING AN INHIBITOR OF MITOCHONDRIAL TRANSCRIPTION Lead Discovery Center GmbH (DE) 2024-03-13 — — EP claimed
WO-2022233782-A1 COMPOSITION COMPRISING AN INHIBITOR OF MITOCHONDRIAL TRANSCRIPTION LEAD DISCOVERY CENTER GMBH (DE) 2022-11-10 — — WO claimed
CN-111386261-B Coumarin derivatives, process for their preparation and their use in the treatment of cancer 利德发现中心有限责任公司 2024-03-22 — — CN disclosed
Send feedback